Skip to main
INSP

INSP Stock Forecast & Price Target

INSP Analyst Ratings

Based on 15 analyst ratings
Hold
Strong Buy 13%
Buy 20%
Hold 60%
Sell 0%
Strong Sell 7%

Bulls say

Inspire Medical Systems is a medical technology company that offers a neurostimulation technology called the Inspire system, which provides a safe and effective treatment for obstructive sleep apnea. Despite facing challenges in the past with a volatile reimbursement environment, the company has shown signs of improvement, with 2Q26 results exceeding expectations. Upcoming potential catalysts, such as the CPTEditorial Panel, final CMS codes, and an increasing contribution from the replacement cycle, could lead to further growth for the company. Additionally, the company's strong cash position, healthy gross margins, and profitability make it an attractive investment opportunity. With potential downside risks, such as competition and changes in reimbursement, our analysis suggests a positive outlook for Inspire Medical Systems.

Bears say

Inspire Medical Systems is facing risks to its target price, including reimbursement and coding changes, long-term impacts of competing pharmaceutical solutions, and lower-than-expected adoption of its Inspire therapy. Adjusted estimates for 2027 have been decreased, and the company is facing confusion and fogginess around reimbursement and coding. While their recently launched Inspire V device offers potential, it is still facing headwinds in terms of inventory dynamics and patient warehousing, and faces stiff competition from other medical solutions in the market.

INSP has been analyzed by 15 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 20% recommend Buy, 60% suggest Holding, 0% advise Selling, and 7% predict a Strong Sell.

This aggregate rating is based on analysts' research of Inspire Medical Systems Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Inspire Medical Systems Inc (INSP) Forecast

Analysts have given INSP a Hold based on their latest research and market trends.

According to 15 analysts, INSP has a Hold consensus rating as of Sep 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $73.53, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $73.53, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Inspire Medical Systems Inc (INSP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.